Investors / Japan / Fast Track Initiative
Fast Track Initiative
Venture capital · Tokyo, Japan · Asia Pacific
Fast Track Initiative is a healthcare-focused venture capital firm established in 2004. It supports startups with science and technology seeds, connecting capital, people, knowledge and networks between Japan and the world to turn discoveries into new medical treatments.
Invests inHealthcare & Biotech
In its own wordshealthcarelife sciencesbiotechregenerative medicinetherapeuticsmedical technology
Your fit with Fast Track Initiative
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsFast Track Initiative lists 26 checked portfolio companies on its own site and is named in 5 funding rounds, 2 of them as lead. Its most frequent entry is Series A, 40% of the companies with a known first round. Its largest themes are Healthcare & Biotech (86%), Industrial & Manufacturing (4%) and AI & Machine Learning (4%). 78% of its companies are based in Japan. It invests most often alongside UTokyo Innovation Platform, Global Brain and Angel Bridge.
Counts come from funding rounds that name Fast Track Initiative, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Fast Track Initiative's whole history. Rounds on record name 5 companies; its own site lists 26. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundFast Track Initiative does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 20% |
| Series A | 40% |
| Series B | 20% |
| Growth | 20% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 4 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 62th | 26 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 58th | 20% of entries at pre-seed or seed |
| Evidence | 80th | 12% of companies confirmed by a round |
| Sector focus | 94th | 86% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| UTokyo Innovation Platform | 4 |
| Global Brain | 3 |
| Angel Bridge | 2 |
| DBJ Capital | 2 |
| Globis Capital Partners | 2 |
| JAFCO | 2 |
| JIC Venture Growth Investments | 2 |
| Kyoto University Innovation Capital | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers26100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 86% | 15% |
| Industrial & Manufacturing | 4% | 7% |
| AI & Machine Learning | 4% | 18% |
| Cybersecurity | 4% | 4% |
| Human Resources | 4% | 1% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with UTokyo Innovation Platform
Compare Fast Track Initiative head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Fast Track Initiative| Date | Company | Stage |
|---|---|---|
| 15 Sept 2026 | Series A | |
| 11 May 2026 | Seed | |
| 8 Sept 2025 | Series B Led |
Round details for Fast Track Initiative
Amounts, full round histories and every co-investor in Fast Track Initiative's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
26 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| A10 Lab develops and provides habit-forming apps and services for individuals and organizations. | Healthcare & Biotech | Portfolio page | ||
| AccuRna develops nucleic acid therapeutics and a drug delivery system for them | Healthcare & Biotech | Portfolio page | ||
| Airna is developing novel medicines with the potential to deliver functional cures for patients using RNA editing technology. | Healthcare & Biotech | Portfolio page | ||
| Alivexis, Inc. develops small-molecule targeted therapeutics through integration of biology insights, technology, and operations. | Healthcare & Biotech | Portfolio page | ||
| The company develops cell therapies and antibodies for cancer treatment | Healthcare & Biotech | Portfolio page | ||
| The company provides online medical consultations and home visits by doctors. | Healthcare & Biotech | Portfolio page | ||
| Global Vascular develops and provides medical devices, including the BioStealth stent, for vascular treatment. | Healthcare & Biotech | Portfolio page | ||
| The company provides visiting care services, including daily life support and nursing care, to individuals in their own homes. | Healthcare & Biotech | Portfolio page | ||
| LUCA Science is a pre-clinical stage biotechnology company focused on developing functional mitochondria as therapeutic agents | Healthcare & Biotech | Portfolio page | ||
| Medii provides a platform for doctors to access information and consult with specialists, aiming to improve medical decision-making and patient care. | Healthcare & Biotech | Portfolio page | ||
| The company provides medical interpretation and translation services for foreign patients in Japan. | Healthcare & Biotech | Portfolio page | ||
| The company develops and provides medical treatments and pharmaceuticals based on gut microbiome research. | Healthcare & Biotech | Sept 2025Series B | Page + round | |
| Mental Health Technologies integrates with EMR systems to automate behavioral health screening and referral processes | Healthcare & Biotech | Portfolio page | ||
| Modalis transforms data into actionable insights and automates work with computational solutions | Healthcare & Biotech | Portfolio page | ||
| The company develops new medicines using its discovery engine technology to promote the potential of GPCR-targeted antibodies | Healthcare & Biotech | Portfolio page | ||
| Neusignal Therapeutics develops treatment drugs for dementia, including Alzheimer's disease | Healthcare & Biotech | Portfolio page | ||
| NovAccel develops and manufactures advanced accelerator technology for cancer treatment, including superconducting accelerators and medical radioisotopes. | Healthcare & BiotechIndustrial & Manufacturing | May 2026Seed | Page + round | |
| Pentas develops and manufactures medical devices, including stents and microcatheters, for neuroendovascular therapy. | Healthcare & Biotech | Portfolio page | ||
| PuREC develops bone regenerative cell therapy using purified Mesenchymal Stem Cells | Healthcare & Biotech | Portfolio page | ||
| The company helps organizations define and communicate their employer value proposition to improve hiring, engagement, and loyalty. | Human Resources | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- fti.vc
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 8 Sept 2025
- Companies checked
- 26
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Fast Track Initiative's profile as data
Pull Fast Track Initiative's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/fti.vc
# also
GET /v1/firms/fti.vc/portfolio
GET /v1/firms/fti.vc/coinvestors
GET /v1/firms/fti.vc/news